Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu

Nym is a fully autonomous medical coding solution that provides high quality, compliant, and
fully transparent coding in seconds, with no human intervention.

By using Nym, health systems and provider groups benefit from reduced operational costs,
decreased denial rates, and ensured compliance readiness.

Nym’s Clinical Language Understanding (CLU) technology is the only medical coding
technology that achieves highly accurate and fully-autonomous coding in seconds along with a
comprehensive audit trail explaining the coding rationale for each chart.

Nym Health - HLTH 2021 Sponsor

Pregnancy care is outdated and ripe for reinvention. US maternal mortality rates have increased by more than 50% over the last 25 years and 60% of these deaths could have been prevented with better knowledge about and access to quality pregnancy care. With nearly half of US counties without an OB, recommended pregnancy monitoring is cumbersome for expectant moms to access, requiring time off work, childcare, or other coverage for hours at a time, often several times a week for routine monitoring.<br><br>Nuvo Group is committed to serving providers and expectant mothers by advancing pregnancy care with new technology, tools and practices. The INVU platform combines proprietary hardware for data collection, innovative cloud-based software for computational power and AI tools to optimize the pregnancy care experience on a global scale. INVU received a 510(k) clearance from the U.S. FDA for maternal and fetal heart rate monitoring in 2020 and a supplemental clearance for remote monitoring of uterine activity in May of 2021. Company leadership is comprised of dedicated data engineers, experienced medical and business professionals, software designers and proud parents who embrace a collective mission to give every life a better beginning.

Nuvo - HLTH 2021 Sponsor

With offices in Boston, MA and Stockholm, Sweden, NuvoAir is a leading digital health company for chronic disease management and decentralized clinical trials. The NuvoAir Home platform blends high-touch care coordination services with connected devices to enable patients, plans and providers the ability to proactively manage chronic conditions, resulting in better outcomes at lower costs. NuvoAir Home currently supports thousands of patients worldwide with COPD, cystic fibrosis, severe asthma, IPF, ALS, and muscular dystrophy. NuvoAir&#39;s decentralized clinical trial solution has been used in over 30 studies globally across all phases of drug development.

NuvoAir - HLTH 2021 Sponsor